Ad
related to: when did flomax come out for cancer medication in men cost insurance
Search results
Results From The WOW.Com Content Network
Tamsulosin was first marketed in 1996 under the trade name Flomax. The U.S. patent expired in October 2009. [26] The U.S. Food and Drug Administration (FDA) approved generics in March 2010. [27] In 2010, tamsulosin was available as OTC medication in UK. [28] It is marketed by various companies under licence, including Boehringer Ingelheim and CSL.
It is a combination of two previously existing medications: dutasteride, brand name Avodart, and tamsulosin, brand name Flomax. It contains 0.5 mg of dutasteride and 0.4 mg of tamsulosin hydrochloride .
Adverse effects from finasteride are rare in men with already enlarged prostates; [12] however, some men experience sexual dysfunction, depression, and breast enlargement. [13] [14] In some men, sexual dysfunction may persist after stopping the medication. [15] [16] It may also hide the early symptoms of certain forms of prostate cancer. [14]
Key takeaways. Life insurance is available for cancer patients, though options and rates vary widely. The stage, type and history of cancer all impact life insurance eligibility and cost.
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer
Within the year of 2014, the cost of prescriptions had increased by at least 11.4% and 58% within the last eight years. The average cost for a month supply of brand-name drugs can run up to a couple of hundred US dollars, whereas in Canada and Great Britain the same medication could cost up to $40 US dollars.
Cancer insurance is a type of supplemental health insurance that is meant to manage the risks associated with the cancer disease and its numerous manifestations. Cancer insurance is a relatively new trend within the insurance industry. It is meant to mitigate the costs of cancer treatment and provide policyholders with a degree of financial ...
(Reuters) -Pfizer said on Tuesday its drug, Adcetris, extended survival in patients with the most common type of lymphoma in a late-stage study, bolstering efforts to expand the use of the ...